Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value ($000): $1,689,747 (100.0% shares, 0.0% debt)

Holdings (42)

INVITAE CORP 16.2%
Value ($000) $273,638 Shares 9,033,943 Est. Cost $3884.53 Unrealized
BLUEPRINT MEDICINES CORP 7.2%
Value ($000) $120,900 Shares 1,550,000 Est. Cost $5615.52 Unrealized
FATE FATE THERAPEUTICS INC 6.2%
Value ($000) $104,646 Shares 3,050,000 Est. Cost $8.50 Unrealized +250.4%
SRPT SAREPTA THERAPEUTICS INC 5.0%
Value ($000) $84,980 Shares 530,000 Est. Cost $121.78 Unrealized +11.7%
MYOKARDIA INC 5.0%
Value ($000) $84,059 Shares 870,000 Est. Cost $39.07 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 4.8%
Value ($000) $81,461 Shares 550,000 Est. Cost $85.45 Unrealized +57.8%
BLFS BIOLIFE SOLUTIONS INC 4.7%
Value ($000) $79,290 Shares 4,849,524 Est. Cost $14.61 Unrealized -5.6%
BLUEBIRD BIO INC 4.0%
Value ($000) $67,449 Shares 1,105,000 Est. Cost $21744.46 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 3.4%
Value ($000) $57,224 Shares 1,070,000 Est. Cost $50.94 Unrealized -9.1%
CDXS CODEXIS INC 3.2%
Value ($000) $53,497 Shares 4,692,732 Est. Cost $13.94 Unrealized -19.0%
BURNING ROCK BIOTECH LTD 2.8%
Value ($000) $46,749 Shares 1,730,786 Est. Cost $27.01 Unrealized
TWST TWIST BIOSCIENCE CORP 2.7%
Value ($000) $45,300 Shares 1,000,000 Est. Cost $26.75 Unrealized +34.1%
CDNA CAREDX INC 2.5%
Value ($000) $42,280 Shares 1,193,335 Est. Cost $24.07 Unrealized +18.3%
RVMD REVOLUTION MEDICINES INC 2.5%
Value ($000) $42,131 Shares 1,334,536 Est. Cost $27.73 Unrealized +13.4%
ADVERUM BIOTECHNOLOGIES INC 2.3%
Value ($000) $38,941 Shares 1,865,000 Est. Cost $14.18 Unrealized
ADPT ADAPTIVE BIOTECHNOLOGIES COR 2.0%
Value ($000) $34,501 Shares 713,125 Est. Cost $37.47 Unrealized -2.7%
GENERATION BIO CO 2.0%
Value ($000) $33,835 Shares 1,611,214 Est. Cost $21.00 Unrealized
DNLI DENALI THERAPEUTICS INC 1.9%
Value ($000) $31,676 Shares 1,310,000 Est. Cost $18.95 Unrealized +24.1%
CONSTELLATION PHARMCETICLS I 1.7%
Value ($000) $29,449 Shares 980,000 Est. Cost $6.31 Unrealized
ONC BEIGENE LTD 1.7%
Value ($000) $28,260 Shares 150,000 Est. Cost $188.40 Unrealized
ALLO ALLOGENE THERAPEUTICS INC 1.6%
Value ($000) $26,763 Shares 625,000 Est. Cost $26.29 Unrealized +37.6%
FULC FULCRUM THERAPEUTICS INC 1.6%
Value ($000) $26,359 Shares 1,441,176 Est. Cost $11.41 Unrealized +37.9%
ALEC ALECTOR INC 1.6%
Value ($000) $26,298 Shares 1,076,039 Est. Cost $18.52 Unrealized +49.1%
MAGENTA THERAPEUTICS INC 1.5%
Value ($000) $25,129 Shares 3,346,034 Est. Cost $1663.66 Unrealized
AMYRIS INC 1.4%
Value ($000) $22,842 Shares 5,349,376 Est. Cost $4.27 Unrealized
CRSP CRISPR THERAPEUTICS AG 1.2%
Value ($000) $19,580 Shares 266,430 Est. Cost $51.63 Unrealized +13.2%
GLOBAL BLOOD THERAPEUTICS IN 1.1%
Value ($000) $18,939 Shares 300,000 Est. Cost $32.45 Unrealized
DMTKQ DERMTECH INC 1.1%
Value ($000) $18,900 Shares 1,428,572 Est. Cost $11.88 Unrealized
ZLAB ZAI LAB LTD 0.9%
Value ($000) $15,605 Shares 190,000 Est. Cost $51.48 Unrealized
SGMO SANGAMO THERAPEUTICS INC 0.8%
Value ($000) $13,037 Shares 1,455,000 Est. Cost $8.80 Unrealized +5.5%
GRITSTONE ONCOLOGY INC 0.7%
Value ($000) $12,286 Shares 1,850,373 Est. Cost $3195.68 Unrealized
BDTX BLACK DIAMOND THERAPEUTICS I 0.7%
Value ($000) $12,201 Shares 289,395 Est. Cost $30.22 Unrealized +21.8%
ILMN ILLUMINA INC 0.7%
Value ($000) $11,111 Shares 30,000 Est. Cost $196.93 Unrealized +63.4%
BRISTOL-MYERS SQUIBB CO 0.6%
Value ($000) $10,561 Shares 2,950,000 Est. Cost $3.36 Unrealized
ORCHARD THERAPEUTICS PLC 0.6%
Value ($000) $9,900 Shares 1,650,000 Est. Cost $2367.29 Unrealized
VYGR VOYAGER THERAPEUTICS INC 0.6%
Value ($000) $9,465 Shares 750,000 Est. Cost $14.86 Unrealized
ORIC ORIC PHARMACEUTICALS INC 0.5%
Value ($000) $8,484 Shares 251,515 Est. Cost $31.92 Unrealized 0.0%
LEGN LEGEND BIOTECH CORP 0.3%
Value ($000) $5,746 Shares 135,000 Est. Cost $42.56 Unrealized
TURNING POINT THERAPEUTICS I 0.3%
Value ($000) $4,844 Shares 75,000 Est. Cost $40080.00 Unrealized
ZYMEWORKS INC 0.3%
Value ($000) $4,689 Shares 130,000 Est. Cost $36.07 Unrealized
DECIPHERA PHARMACEUTICALS IN 0.2%
Value ($000) $3,882 Shares 65,000 Est. Cost $13347.64 Unrealized
STOK STOKE THERAPEUTICS INC 0.2%
Value ($000) $2,860 Shares 120,000 Est. Cost $27.21 Unrealized -12.8%